Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Patients With Colorectal Cancer

This study has been completed.
Information provided by:
Eli Lilly and Company Identifier:
First received: February 16, 2007
Last updated: April 16, 2010
Last verified: April 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2009
  Primary Completion Date: May 2009 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: April 16, 2010